Thor Medical ASA (OSL:TRMED)
Norway flag Norway · Delayed Price · Currency is NOK
4.775
+0.075 (1.60%)
Sep 14, 2026, 12:33 PM CET

Thor Medical ASA Financials Overview

Millions NOK. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Revenue
1.640.84---
Revenue Growth
95.35%----
Gross Profit
1.640.84---
Operating Income
-82.85-69.65-43.93-7.16-
Net Income
-83.01-58.01-42.21-26.56-311.24
Earnings Per Share
-0.23-0.17-0.18-0.15-2.70
EPS Growth
-----

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Investments
59.9180.56123.3941.7798.72
Total Debt
242.2171.380.74-0.16
Net Cash (Debt)
-182.39.18122.6541.7798.56
Net Cash Growth
--92.52%193.66%-57.62%-
Net Cash Per Share
-0.510.030.520.240.86

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Operating Cash Flow
-90.94-47.54-23.98-64.09-409.08
Capital Expenditures
-145.81-73.11-0.14--5.63
Free Cash Flow
-236.75-120.65-24.12-64.09-414.71
Free Cash Flow Growth
-----

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Gross Margin
100.00%100.00%---
Operating Margin
-5055.10%-8301.91%---
Pretax Margin
-5324.47%-7421.69%---
Profit Margin
-5064.80%-6914.42%---
FCF Margin
-14444.66%-14379.98%---

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22
PS Ratio
1211.572215.62---